• Other


    2016

    Agh T, Inotai A: Patient Reported Outcomes. Principles of Measurement and Applicability in Economic Evaluation (e-book). Eötvös Loránd University, Faculty of Social Sciences, Budapest, 2016. ISBN: 978-963-284-747-4. Link

    2014

    Inotai A, Lovas K, Kalo Z (eds). [Patient Reported Outcomes]. SprindMed Kiado, Budapest, 2014. [in Hungarian] ISBN: 978-963-9695-15-3 Link

    2012

    Kalo Z, Meresz G, Mezei D, Tótth A, Inotai A: The grounding and implications of Szell Kalman Plan [Full Report, in Hungarian, based on the paper: Kalo et al.: IME, 2012; 11:6,12-16]. Link

    2011

    Inotai A: Pharmacoeconomic aspects of oral nonsteroidal antiinflammatory drugs in rheumatoid arthritis focusing on the selective COX-2 inhibitor celecoxib. Ph.D. thesis (2011) Link

    2010

    Kalo Z, Inotai A, Lukovics M: Health Economic Syllabus II. Economic Analysis of Health Market, Finance and Investment. Budapest, Professional Publishing Hungary Kft. Medical Tribune, 2010

    2009

    Nagy B: Risk adjustment for the allocation of health care resources in Hungary - development of the capitation payment formula. Ph.D. thesis (2009) Link

    Rozsa S, Brandtmuller A, Nagy B, Brennan A, Akehurst R: The psychometric properties of ADCS - Activities of Daily Living Inventory and comparison of different ADL scores. ScHARR Discussion papers 2009, No. 09/05 Link

    Kalo Z, Inotai A, Nagyjanosi L. Health Economic Syllabus I. Economic Analysis of Health Technologies. Budapest, Professional Publishing Hungary Kft. Medical Tribune, 2009

    2008

    Kalo, Z., Docteur, E. and Moïse, P: Pharmaceutical pricing and reimbursement policies in Slovakia, OECD Health Working Paper, No. 31, Paris. 2008 Link

    Voko Z, Adany R: Driving Improved Health Intelligence In: Wismar M, McKee, M Ernst K, Srivastava D, Busse R (szerk.) Health targets in Europe: Learning from experience Kopenhagen: WHO Regional Publications, 2008. p. 137-147. (Observatory studies series; 13.) Link